Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 1 | 1 | 0 (0.0%) |
| Value | $2.54K | $2.54K | $0 (0.0%) |
New holders (0)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (0)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
None.